MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
IQVIA Holdings Total Shareholders Equity 2011-2026 | IQV
Annual Total Shareholders Equity IQVIA Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.5 B | 6.07 B | 6.11 B | 5.76 B | 6.04 B | 6.28 B | 6 B | 6.71 B | 8.11 B | 8.63 B | -564 M | -704 M | -667 M | -1.36 B | -970 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.63 B | -1.36 B | 4.13 B |
Quarterly Total Shareholders Equity IQVIA Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.22 B | 6.5 B | 5.78 B | 5.98 B | 6.07 B | 6.97 B | 6.71 B | 6.34 B | 6.11 B | 5.8 B | 5.75 B | 5.93 B | 5.76 B | 5.35 B | 5.35 B | 5.92 B | 6.04 B | 5.83 B | 5.76 B | 6.24 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6.71 B | 6.71 B | 6.71 B | 6.71 B | 8 B | 8 B | 8 B | 8 B | 8.63 B | 8.63 B | 8.63 B | 8.63 B | -564 M | -564 M | -564 M | -564 M | -704 M | -704 M | -704 M | -704 M | -667 M | -667 M | -667 M | -667 M | -1.36 B | -1.36 B | -1.36 B | -1.36 B | -970 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.63 B | -1.36 B | 4.34 B |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Agilent Technologies
A
|
5.39 B | $ 111.7 | -1.36 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
471 M | $ 19.13 | 1.32 % | $ 555 M | USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 15.7 | -3.03 % | $ 475 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 142.54 | -0.49 % | $ 22.7 B | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 415.27 | -0.93 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
368 M | $ 3.58 | -1.1 % | $ 332 M | USA |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
837 M | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
14 M | $ 18.62 | -1.64 % | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 150.85 | -5.3 % | $ 7.48 B | USA |
 |
Natera
NTRA
|
706 M | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
11 B | $ 25.23 | -1.06 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
-99.3 M | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
261 M | $ 6.36 | -5.22 % | $ 568 M | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
61 M | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Soleno Therapeutics
SLNO
|
450 M | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
4.1 M | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 438.34 | -2.2 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
-35.2 M | $ 0.57 | -1.59 % | $ 205 M | Irlanda |
 |
Celcuity
CELC
|
101 M | $ 137.68 | 2.2 % | $ 6.44 B | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 186.61 | -0.71 % | $ 20.7 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |